Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,26 MB, PDF-dokument

The dopamine (DA) transporter (DAT) is part of a presynaptic multiprotein network involving interactions with scaffold proteins via its C-terminal PDZ domain-binding sequence. Using a mouse model expressing DAT with mutated PDZ-binding sequence (DAT-AAA), we previously demonstrated the importance of this binding sequence for striatal expression of DAT. Here, we show by application of direct stochastic reconstruction microscopy not only that the striatal level of transporter is reduced in DAT-AAA mice but also that the nanoscale distribution of this transporter is altered with a higher propensity of DAT-AAA to localize to irregular nanodomains in dopaminergic terminals. In parallel, we observe mesostriatal DA adaptations and changes in DA-related behaviors distinct from those seen in other genetic DAT mouse models. DA levels in the striatum are reduced to ∼45% of that of WT, accompanied by elevated DA turnover. Nonetheless, fast-scan cyclic voltammetry recordings on striatal slices reveal a larger amplitude and prolonged clearance rate of evoked DA release in DAT-AAA mice compared with WT mice. Autoradiography and radioligand binding show reduced DA D2 receptor levels, whereas immunohistochemistry and autoradiography show unchanged DA D1 receptor levels. In behavioral experiments, we observe enhanced self-administration of liquid food under both a fixed ratio of one and progressive ratio schedule of reinforcement but a reduction compared with WT when using cocaine as reinforcer. In summary, our data demonstrate how disruption of PDZ domain interactions causes changes in DAT expression and its nanoscopic distribution that in turn alter DA clearance dynamics and related behaviors.

OriginalsprogEngelsk
Artikelnummer101361
TidsskriftJournal of Biological Chemistry
Vol/bind297
Udgave nummer6
ISSN0021-9258
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
Funding and additional information—The work was supported by the University of Copenhagen BioScaRT Program of Excellence (to G. S., D. W., G. W., A. F.-J., and U. G.), the National Institutes of Health grants P01 DA 12408 (to U. G.), Independent Research Fund Denmark—Medical Sciences (4004-00097B to U. G.), Lundbeck Foundation R199-2015-2110 and R77-2010-6815 (to U. G. and M. R.), the Novo Nordisk Foundation (NNF16OC0023104) (to U. G.), and St. Petersburg State University, St. Petersburg, Russia (project ID: 51143531) (to R. R. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2021 THE AUTHORS.

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 287607053